Cargando…

Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?

Detalles Bibliográficos
Autores principales:	D’Antongiovanni, Vanessa, Fornai, Matteo, Pellegrini, Carolina, Blandizzi, Corrado, Antonioli, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848115/ https://www.ncbi.nlm.nih.gov/pubmed/33536924 http://dx.doi.org/10.3389/fphar.2020.621955

Ejemplares similares

The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2020)

Intestinal epithelial barrier and neuromuscular compartment in health and disease
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2020)

Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease
por: Benvenuti, Laura, et al.
Publicado: (2020)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2018)

Glial A(2B) Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2020)

Inflammatory Bowel Diseases: It's Time for the Adenosine System
por: Antonioli, Luca, et al.
Publicado: (2020)

Donepezil improves vascular function in a mouse model of Alzheimer’s disease
por: Pellegrini, Carolina, et al.
Publicado: (2021)

Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2021)

Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2023)

From the intestinal mucosal barrier to the enteric neuromuscular compartment: An integrated overview on the morphological changes in Parkinson’s disease
por: Pellegrini, Carolina, et al.
Publicado: (2021)

Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
por: Dal Ben, Diego, et al.
Publicado: (2018)

NKG2A and COVID-19: another brick in the wall
por: Antonioli, Luca, et al.
Publicado: (2020)

The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice
por: Panattoni, Adelaide, et al.
Publicado: (2022)

Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
por: Pellegrini, Carolina, et al.
Publicado: (2019)

Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity
por: Gentile, Daniela, et al.
Publicado: (2018)

Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2017)

Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention
por: Colucci, Rocchina, et al.
Publicado: (2018)

Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy
por: Rota, Lucia, et al.
Publicado: (2019)

The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A(3) Receptor Agonist, in a Rat Model of Colitis
por: Antonioli, Luca, et al.
Publicado: (2020)

Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation
por: Antonioli, Luca, et al.
Publicado: (2021)

Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
por: Pellegrini, C., et al.
Publicado: (2022)

Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
por: Pellegrini, C., et al.
Publicado: (2023)

High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse
por: Piccarducci, Rebecca, et al.
Publicado: (2019)

Prodromal Intestinal Events in Alzheimer’s Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition
por: Pellegrini, Carolina, et al.
Publicado: (2020)

Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2022)

Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats
por: Antonioli, Luca, et al.
Publicado: (2014)

The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity
por: Gentile, Daniela, et al.
Publicado: (2018)

Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
por: Pellegrini, Carolina, et al.
Publicado: (2016)

Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon
por: Segnani, Cristina, et al.
Publicado: (2015)

Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
por: Ferraro, Sara, et al.
Publicado: (2019)

Editorial: Neurological, Metabolic and Inflammatory Disorders: A Common Root in Inflammasome
por: Pellegrini, Carolina, et al.
Publicado: (2021)

An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis
por: Ippolito, Chiara, et al.
Publicado: (2015)

Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship
por: Lucarini, Elena, et al.
Publicado: (2020)

Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction
por: Campos-Martins, Alexandrina, et al.
Publicado: (2021)

A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa
por: Piano, Ilaria, et al.
Publicado: (2019)

Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis
por: Vecchio, Elizabeth A., et al.
Publicado: (2017)

Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors
por: Schirmbeck, Frederike, et al.
Publicado: (2013)

A network pharmacology approach to predict potential targets and mechanisms of “Ramulus Cinnamomi (cassiae) – Paeonia lactiflora” herb pair in the treatment of chronic pain with comorbid anxiety and depression
por: Pan, Hao-Tian, et al.
Publicado: (2022)

Pharmacological Insights Into Safety and Efficacy Determinants for the Development of Adenosine Receptor Biased Agonists in the Treatment of Heart Failure
por: Rueda, Patricia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ndkbjqej76ha5578skc9k8hbtm